These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 16553136
1. Cancer-associated thrombosis: focus on extended therapy with dalteparin. Bick RL. J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136 [Abstract] [Full Text] [Related]
2. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J, Goodin S. J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108 [Abstract] [Full Text] [Related]
3. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M, Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. N Engl J Med; 2003 Jul 10; 349(2):146-53. PubMed ID: 12853587 [Abstract] [Full Text] [Related]
4. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care? Burris HA. Semin Oncol; 2006 Apr 10; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456 [Abstract] [Full Text] [Related]
10. Selecting an anticoagulant for recurrent venous thromboembolism in cancer. Goodin S. Am J Health Syst Pharm; 2005 Nov 15; 62(22 Suppl 5):S10-3. PubMed ID: 16286363 [Abstract] [Full Text] [Related]
11. Outpatient management of anticoagulation therapy. du Breuil AL, Umland EM. Am Fam Physician; 2007 Apr 01; 75(7):1031-42. PubMed ID: 17427618 [Abstract] [Full Text] [Related]
12. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. Lee AY, Rickles FR, Julian JA, Gent M, Baker RI, Bowden C, Kakkar AK, Prins M, Levine MN. J Clin Oncol; 2005 Apr 01; 23(10):2123-9. PubMed ID: 15699480 [Abstract] [Full Text] [Related]
15. Cancer-associated venous thrombosis in the surgical setting. Behranwala KA, Williamson RC. Ann Surg; 2009 Mar 01; 249(3):366-75. PubMed ID: 19247020 [Abstract] [Full Text] [Related]
16. Venous thromboembolism and cancer: risks and outcomes. Lee AY, Levine MN. Circulation; 2003 Jun 17; 107(23 Suppl 1):I17-21. PubMed ID: 12814981 [Abstract] [Full Text] [Related]
18. [Prevention of venous thromboembolism in internal medicine and neurology]. Malý J, Dulícek P, Penka M, Malý R, Gumulec J. Vnitr Lek; 2006 Mar 17; 52 Suppl 1():63-7. PubMed ID: 16637452 [Abstract] [Full Text] [Related]
19. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Caprini JA, Arcelus J, Sehgal LR, Cohen EB, Reyna JJ. Int Angiol; 2002 Mar 17; 21(1):78-85. PubMed ID: 11941278 [Abstract] [Full Text] [Related]
20. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P, Groupe Francophone Thrombose et Cancer (GFTC). Thromb Res; 2010 Apr 17; 125 Suppl 2():S108-16. PubMed ID: 20433988 [Abstract] [Full Text] [Related] Page: [Next] [New Search]